St. John’s Wort Modulates the Toxicities and Pharmacokinetics of CPT-11 (Irinotecan) in Rats
- 8 June 2005
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 22 (6) , 902-914
Abstract
CPT-11 is a DNA topoisomerase I inhibitor for the therapy of colorectal cancer, whereas St. John’s Wort (Hypericum perforatum, SJW) is a widely used herbal anti-depressant. This study aimed to investigate the effects of co-administered SJW on the toxicities and pharmacokinetics of CPT-11 and the underlying mechanisms. The body weight loss, gastrointestinal and hematological toxicities induced by CPT-11, and the pharmacokinetic parameters of CPT-11 were evaluated in rats pretreated with SJW or vehicle. Rats treated with CPT-11 alone experienced rapid decrease in body weight, whereas co-administration of SJW with CPT-11 resulted in lesser body weight loss. The gastrointestinal and hematological toxicities following CPT-11 injection were both alleviated in the presence of SJW. The rat pharmacokinetics of both CPT-11 and its metabolite SN-38 were significantly altered in presence of SJW. In conclusion, co-administered SJW significantly ameliorated the toxicities induced by CPT-11. The protective effect of SJW may be partially due to pharmacokinetic interaction between CPT-11 and SJW.Keywords
This publication has 99 references indexed in Scilit:
- Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients With Solid TumorsJournal of Clinical Oncology, 2005
- Pharmacokinetic Interactions of Drugs with St John’s WortJournal of Psychopharmacology, 2004
- Novel camptothecin analogues that circumvent ABCG2‐associated drug resistance in human tumor cellsInternational Journal of Cancer, 2004
- St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment responseMolecular Psychiatry, 2004
- Anti-Inflammatory Actions of St. John’s Wort: Inhibition of Human Inducible Nitric-Oxide Synthase Expression by Down-Regulating Signal Transducer and Activator of Transcription-1α (STAT-1α) ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- St. John's wort and depressionLife Sciences, 2002
- Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecinXenobiotica, 2001
- Management of Cancer Treatment–Related DiarrheaJournal of Pain and Symptom Management, 2000
- A Comparative Analysis of the Photosensitized Inhibition of Growth-Factor Regulated Protein Kinases by Hypericin-DerivativesBiochemical and Biophysical Research Communications, 1996
- CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties.Journal of Pharmacobio-Dynamics, 1991